CCND1 and colorectal cancer: This is not unexpected as there is evidence that suggests the overexpression of cyclin D1 prevents anoikis via inhibition of the transcriptional activity of FoxO proteins [86], which may be a plausible explanation for the upregulation of cyclin D1 observed in the fucoxanthin‐treated colorectal cancer cells.